Intubating Video Stylet Versus Fiberoptic Intubating Bronchoscope.
Launched by CAIRO UNIVERSITY · Dec 2, 2019
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Following approval from Ethics and Research Committee of Theodor Bilharz Research Institute, the study protocol will be explained to the patients after taking their consent.
Upon arrival to the operating room, a 20 G cannula will be sited intravenously and infusion of Ringer's solution will be started. Intravenous midazolam in a dose of 0.05 mg/ Kg will be given. Then, a five-lead electrocardiogram (GE-Datex Ohmeda 5 lead ECG cable), a pulse oximeter (GE- Datex Ohmeda adult finger spO2 sensor) and a non-invasive blood pressure monitor (GE-Datex Ohmeda NIBP cuff, adult double tube with bag)...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient age 18- 60 years.
- • Both sexes
- • American Society of Anesthesiologists(ASA) physical status classes I and II.
- • Non-obese patients ( BMI \<35)
- Exclusion Criteria:
- • Difficult intubation; mallampati 3 or 4, Dental abnormalities, Cervical spine pathology that limits neck mobility , obese patients ( BMI ≥ 35) .
- • Cardiovascular disease, hypertensive patients, Pregnant and nursing women, High risk of pulmonary aspiration.
- • Patients at risk of bleeding either impaired bleeding profile or receiving anticoagulants
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Nesrine Elrefai, MD
Principal Investigator
Professor of Anaesthesia, surgical ICU &Pain management
Sohaila Omar, MD
Principal Investigator
Professor of Anaesthesia and surgical ICU
Mohamed Hussien, MD
Study Director
Lecturer of Anaesthesia and surgical ICU
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials